Yıl: 2012 Cilt: 14 Sayı: 2 Sayfa Aralığı: 105 - 108 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle

Öz:
Pulmoner langerhans hücreli histiyositozis (PLHH), etyolojisi bilinmeyen ve sigara içenlerde görülen, nadir bir interstisyel akciğer hastalığıdır. Hastalıkta genellikle izole akciğer tutulumu vardır ve santral sinir sistemi tutulumu nadirdir. Bu olgu sunumunda, birinde takip, diğerinde ise tanı sırasında santral diabetes insipidus (Dİ) saptanan iki olgu sunulmaktadır. Olgular, yaşları sırasıyla 24 ve 39 olan, sigara içme öyküsü olan erkek hastalardı. İki olgunun da yüksek rezolüsyonlu bilgisayarlı tomografilerinde (YRBT) yaygın kistik lezyonlar izlenmiş olup, video-yardımlı torakoskopik cerrahiyle (VATS) alınan biyopsilerinde PLHH saptandı. Takipte solunum fonksiyonlarının bozulmuş olduğu görülen birinci olguya 0,5 mg/kg metil prednisolon başlandı. Bir ay sonra yapılan kontrolde PLHH için kısmi düzelme gözlenmesi üzerine tedavi 6 aya uzatıldı, tedavi bitiminde tam remisyon saptanarak steroid tedavisi kesildi. İki hastaya da Dİ için oral 0,1 mg/gün desmopressin başlandı, bir ay sonra tam klinik düzelme gözlendi.
Anahtar Kelime:

Konular: Tıbbi Araştırmalar Deneysel Solunum Sistemi Genel ve Dahili Tıp Onkoloji Radyoloji, Nükleer Tıp, Tıbbi Görüntüleme Pediatri

Pulmonary langerhans’ cell histiocytosis and diabetes insipidus: On the occasion of two cases

Öz:
Pulmonary Langerhans’ cell histiocytosis (PLCH) is an uncommon interstitial lung disease with an unknown etiology in smokers. Disease is usually seen with isolated lung involvement and central nervous system involvement is rare.Two PLCH cases, with central diabetes insipidus (DI) determined at diagnosis in one of the cases and during follow-up in the other, is being presented in this report. The patients’ ages were 39 and 24, respectively and they were both male patients with a history of smoking. Widely cystic lesions were viewed at high-resolution computed tomography scans (HRCT) and PLCH was detected at the biopsies obtained by video-assisted thoracoscopic surgery (VATS), in both two cases. Therapy was started with 0.5 mg/kg methyl prednisolone for latter case, because of impairment in pulmonary function tests during follow up. On control, after one month therapy, partial improvement was seen for PLCH and the therapy was continued up to 6 months. At the end of the therapy complete remission was seen and corticotherapy was stopped. Desmopressin was started for both cases at 0.1 mg/day, orally. After one month of treatment clinical improvement was observed during control.
Anahtar Kelime:

Konular: Tıbbi Araştırmalar Deneysel Solunum Sistemi Genel ve Dahili Tıp Onkoloji Radyoloji, Nükleer Tıp, Tıbbi Görüntüleme Pediatri
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH. Pulmonary Langerhans’-cell histiocytosis. N Engl J Med 2000;342:1969–1978.
  • 2. Hance AJ, Basset F, Saumon G, Danel C, Valeyre D, Battesti JP, et al. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci 1986;465:643–656.
  • 3. Timothy CA. Pulmonary Langerhans cell histiocytosis and other pulmonary histiocytic diseases: a review. Arch Pathol Lab Med 2008; 132:1171–1181.
  • 4. Colby TV, Lombard C. Histiocytosis X in the lung. Hum Pathol 1983; 14:847–856.
  • 5. Thomeer M, Demedts M, Vandeurzen K. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg 2001;56:163–172.
  • 6. Watanabe R, Tatsumi K, Hashimoto S, Tamakoshi A, Kuriyama T. Clinico-epidemiological features of pulmonary histiocytosis X. Intern Med 2001;40:998–1003.
  • 7. Youkeles LH, Grizzanti JN, Liao Z, Chang CJ, Rosenstreich DL. Decreased tobacco-glycoprotein-induced lymphocytes in vitro in pulmonary eosinophilic granuloma. Am J Resp Crit Care Med 1995; 151:145–150.
  • 8. Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999;85:2278–2290.
  • 9. Watanabe R, Tatsumi K, Hashimoto S, Tamakoshi A, Kuriyama T. Clinico-epidemiological features of pulmonary histiocytosis X. Intern Med 2001;40:998–1003.
  • 10. Crausman RS, Jennings CA, Tuder RM, Ackerson LM, Irvin CG, King TE Jr. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med 1996; 153: 426– 435.
  • 11. Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans’-cell histiocytosis in adults. N Engl J Med 2002;346:484–490.
  • 12. Mendez JL, Nadrous HF, Vassallo R, Decker PA, Ryu JH. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004;125:1028–1032.
  • 13. Baran R, Şengül C, Sivaslıoğlu S. Histiositozis X. Solunum Hastalıkları 1995;6:255–261.
  • 14. Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans cell histiosytosis in adults. Med Pediatr Oncol 1997;28: 9–14.
  • 15. Douglas NJ, Goetzl EJ. Pulmonary eosinophilia and eosinophilic granuloma. In: Murray JF, Nadel JA Eds. Textbook of Respiratory Medicine. 2nd Ed Philadelphia: WB Saunders Company; 1994, p. 1926–1929.
  • 16. Biber Ç, Yılmaz U, Sönmez A. Pulmoner eozinofilik granulom (Olgu sunumu). Solunum Hastalıkları 1999;10:295–298.
  • 17. Grois N, Pötschger U, Prosch H, Minkov M, Arico M, Braier J, et al. and DALHX- and LCH I and II Study Committee, Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatric Blood Cancer 2006;46:228–233.
  • 18. Prosch H, Grois N, Prayer D, Waldhauser F, Steiner M, Minkov M, et al. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatric Blood Cancer 2004;43:594– 599.
  • 19. Maghnie M, Bossi G, Klersy C, Cosi G, Genovese E, Aricò M. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood Langerhans’ cell histiocytosis. J Clin Endocrinol Metab 1998;83:3089–3094.
  • 20. Haupt R, Nanduri V, Calevo MG, Bernstrand C, Braier JL, Broadbent Vand, et al. Permanent consequences in Langerhans’ cell histiocytosis patients: A pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 2004;42:438–444.
  • 21. Ertürk A, Ünsal E, Gülhan M, Canbakan S, Güler M, Çakır E ve ark. Pulmoner Langerhans hücreli histiyositozis: Sigaranın bıraktırılması ile akciğer lezyonları düzelen bayan olgu. Solunum Dergisi 2007;9:105–109
  • 22. Tazi, A. Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J 2006;27:1272–1285.
APA SEZGİ C, ABAKAY A, TANRIKULU Ç, ŞEN SELİMOĞLU H, ŞENYİĞİT A (2012). Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle. , 105 - 108.
Chicago SEZGİ Cengizhan,ABAKAY Abdurrahman,TANRIKULU Çetin,ŞEN SELİMOĞLU Hatice,ŞENYİĞİT Abdurrahman Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle. (2012): 105 - 108.
MLA SEZGİ Cengizhan,ABAKAY Abdurrahman,TANRIKULU Çetin,ŞEN SELİMOĞLU Hatice,ŞENYİĞİT Abdurrahman Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle. , 2012, ss.105 - 108.
AMA SEZGİ C,ABAKAY A,TANRIKULU Ç,ŞEN SELİMOĞLU H,ŞENYİĞİT A Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle. . 2012; 105 - 108.
Vancouver SEZGİ C,ABAKAY A,TANRIKULU Ç,ŞEN SELİMOĞLU H,ŞENYİĞİT A Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle. . 2012; 105 - 108.
IEEE SEZGİ C,ABAKAY A,TANRIKULU Ç,ŞEN SELİMOĞLU H,ŞENYİĞİT A "Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle." , ss.105 - 108, 2012.
ISNAD SEZGİ, Cengizhan vd. "Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle". (2012), 105-108.
APA SEZGİ C, ABAKAY A, TANRIKULU Ç, ŞEN SELİMOĞLU H, ŞENYİĞİT A (2012). Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle. Solunum, 14(2), 105 - 108.
Chicago SEZGİ Cengizhan,ABAKAY Abdurrahman,TANRIKULU Çetin,ŞEN SELİMOĞLU Hatice,ŞENYİĞİT Abdurrahman Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle. Solunum 14, no.2 (2012): 105 - 108.
MLA SEZGİ Cengizhan,ABAKAY Abdurrahman,TANRIKULU Çetin,ŞEN SELİMOĞLU Hatice,ŞENYİĞİT Abdurrahman Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle. Solunum, vol.14, no.2, 2012, ss.105 - 108.
AMA SEZGİ C,ABAKAY A,TANRIKULU Ç,ŞEN SELİMOĞLU H,ŞENYİĞİT A Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle. Solunum. 2012; 14(2): 105 - 108.
Vancouver SEZGİ C,ABAKAY A,TANRIKULU Ç,ŞEN SELİMOĞLU H,ŞENYİĞİT A Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle. Solunum. 2012; 14(2): 105 - 108.
IEEE SEZGİ C,ABAKAY A,TANRIKULU Ç,ŞEN SELİMOĞLU H,ŞENYİĞİT A "Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle." Solunum, 14, ss.105 - 108, 2012.
ISNAD SEZGİ, Cengizhan vd. "Pulmoner langerhans hücreli histiyositoz ve diabetes insipidus: İki olgu nedeniyle". Solunum 14/2 (2012), 105-108.